X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (909) 909
cd16 antigen (870) 870
life sciences & biomedicine (720) 720
humans (701) 701
immunology (463) 463
flow cytometry (457) 457
monocytes (399) 399
female (356) 356
male (343) 343
cd16 (325) 325
cd14 antigen (320) 320
inflammation (298) 298
adult (283) 283
fc receptors (259) 259
middle aged (250) 250
cytokines (248) 248
natural killer cells (246) 246
leukocytes (241) 241
lymphocytes t (229) 229
lymphocytes (222) 222
multidisciplinary sciences (187) 187
science & technology - other topics (187) 187
medicine (186) 186
killer cells, natural - immunology (170) 170
patients (170) 170
cd3 antigen (169) 169
macrophages (168) 168
research article (168) 168
cd4 antigen (167) 167
cytotoxicity (167) 167
science (165) 165
animals (163) 163
immune system (161) 161
cd56 antigen (158) 158
aged (151) 151
cell activation (150) 150
blood (149) 149
cell biology (148) 148
gene expression (146) 146
peripheral blood (146) 146
receptors, igg - metabolism (145) 145
monocytes - immunology (141) 141
analysis (136) 136
cd8 antigen (133) 133
immune response (124) 124
phenotypes (116) 116
antigens (115) 115
killer cells (115) 115
oncology (115) 115
receptors, igg - immunology (114) 114
proteins (113) 113
histocompatibility antigen hla (112) 112
infections (108) 108
monocytes - metabolism (108) 108
dendritic cells (107) 107
lymphocytes b (107) 107
hematology (103) 103
cancer (98) 98
cells, cultured (98) 98
neutrophils (94) 94
cd19 antigen (93) 93
interleukin 6 (91) 91
t cell receptors (91) 91
mice (90) 90
health aspects (89) 89
immunophenotyping (86) 86
t cells (86) 86
apoptosis (83) 83
young adult (83) 83
cytometry (82) 82
research (81) 81
infectious diseases (80) 80
immune cells (79) 79
immunotherapy (77) 77
medical research (77) 77
receptors (77) 77
biology (76) 76
peripheral blood mononuclear cells (76) 76
antibodies (74) 74
biomarkers (74) 74
chemical and pharmacologic phenomena (74) 74
immunity (74) 74
pathology (73) 73
interleukin 10 (72) 72
adolescent (71) 71
cd14 (70) 70
tumors (69) 69
biochemistry & molecular biology (68) 68
immunoglobulins (68) 68
nk cells (68) 68
tumor necrosis factor-α (68) 68
γ-interferon (67) 67
human immunodeficiency virus--hiv (66) 66
lipopolysaccharides (66) 66
pathogenesis (66) 66
phenotype (66) 66
cd11b antigen (65) 65
hiv (65) 65
interferon (65) 65
white blood cells (64) 64
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0186343 - e0186343
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, pp. e0139474 - e0139474
... to inflammation and coagulation in HIV-1 infection [1-3]. These antigen-presenting cells can be segregated into three functionally distinct populations based on CD14 and CD16... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | HIV-1 | Humans | Middle Aged | Raltegravir Potassium - therapeutic use | Receptors, Chemokine - analysis | Male | HIV Integrase Inhibitors - administration & dosage | Viral Load | Antigens, CD - analysis | HIV Infections - immunology | Flow Cytometry | HIV Infections - pathology | Adult | Anti-HIV Agents - therapeutic use | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - therapeutic use | Female | Monocytes - classification | HIV Infections - blood | Cell Separation | Immunophenotyping | Viremia - drug therapy | Receptors, CCR2 - analysis | Antiretroviral Therapy, Highly Active | Viremia - pathology | HIV Integrase Inhibitors - therapeutic use | HLA-DR Antigens - analysis | HIV Infections - drug therapy | Viremia - immunology | CX3C Chemokine Receptor 1 | Drug Combinations | Antiviral agents | Care and treatment | Vascular endothelium | Dosage and administration | Genetic aspects | Diagnosis | Research | Integrase inhibitors | HIV infection | Risk factors | CC chemokine receptors | Therapy | Flow cytometry | CD40 antigen | CD86 antigen | Fluorescence | CD13 antigen | CX3CR1 protein | Leukocytes (mononuclear) | Infections | CD14 antigen | Density | Receptors | CCR2 protein | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Cryopreservation | CD38 antigen | Human immunodeficiency virus--HIV | Patrols | Peripheral blood mononuclear cells | Integrase | Antiretroviral drugs | Phenotypes | Markers | Health risks | CD36 antigen | Risk analysis | Patients | Chemokine receptors | Antiretroviral therapy | CD163 antigen | CD83 antigen | Cytometry | CD16 antigen | Monocytes | Womens health | Histocompatibility antigen HLA | Cardiovascular diseases | Monocyte chemoattractant protein 1 | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Scientific reports, ISSN 2045-2322, 09/2017, Volume 7, Issue 1, pp. 12100 - 13
Journal Article
Osteoporosis international, ISSN 0937-941X, 3/2017, Volume 28, Issue 3, pp. 991 - 999
Journal Article
The lancet oncology, ISSN 1470-2045, 02/2016, Volume 17, Issue 2, pp. 212 - 223
Summary Background MUC1 is a tumour-associated antigen expressed by many solid tumours, including non-small-cell lung cancer... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Fatigue - etiology | Male | Cisplatin - administration & dosage | Antigens, CD - analysis | Antigens, Differentiation, T-Lymphocyte - analysis | Neutropenia - etiology | Cancer Vaccines - therapeutic use | Receptors, IgG - analysis | Mucin-1 - analysis | Lectins, C-Type - analysis | Female | Paclitaxel - administration & dosage | Lymphocytes - chemistry | Anemia - etiology | Bevacizumab - administration & dosage | Double-Blind Method | Lung Neoplasms - chemistry | Lymphocyte Activation | CD56 Antigen - analysis | Deoxycytidine - administration & dosage | Erlotinib Hydrochloride - administration & dosage | Carboplatin - administration & dosage | Cancer Vaccines - adverse effects | Lung Neoplasms - therapy | Immunotherapy - adverse effects | Biomarkers, Tumor - blood | Disease-Free Survival | Carcinoma, Non-Small-Cell Lung - therapy | Membrane Glycoproteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pemetrexed - administration & dosage | Aged | Membrane Glycoproteins - adverse effects | Deoxycytidine - analogs & derivatives | Antigens | Fc receptors | Hospitals | Interleukins | Immunotherapy | Mucins | Clinical trials | Product development | Lung cancer, Non-small cell | Analysis | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, pp. e30264 - e30264
... obstacle for NK-cell immunotherapy. Genetically-engineered artificial antigen-presenting cells (aAPCs... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Cell Proliferation | Artificial Cells - immunology | Coculture Techniques | Humans | Antibody-Dependent Cell Cytotoxicity - immunology | Gene Expression Profiling | Interleukin-15 - immunology | Interleukins - metabolism | Flow Cytometry | T-Lymphocytes - metabolism | U937 Cells | Interleukins - immunology | Receptors, KIR - metabolism | Killer Cells, Natural - immunology | Membrane Proteins - metabolism | Telomere - genetics | Cell Line | Antigen-Presenting Cells - metabolism | Immunotherapy, Adoptive - methods | Cells, Cultured | Immunophenotyping | Membrane Proteins - immunology | Antigen-Presenting Cells - immunology | Artificial Cells - metabolism | Interleukin-15 - metabolism | K562 Cells | Cell Line, Tumor | T-Lymphocytes - immunology | Killer Cells, Natural - metabolism | Receptors, KIR - immunology | Antigens | Fc receptors | Telomeres | Killer cells | Health aspects | Immunotherapy | Cell proliferation | Lymphocyte receptors | Cell culture | Pediatrics | Senescence | Transplants & implants | Transcription | Toxicity | Adoptive immunotherapy | Erythrocytes | Multiple myeloma | Science | Clinical trials | Cytotoxicity | Leukocytes | Cancer therapies | NKG2 antigen | Cell growth | Lymphocytes | Interleukin 21 | Killer cell immunoglobulin-like receptors | Biocompatibility | Natural killer cells | Expansion | Killing | Cytomegalovirus | Cytokines | Dendritic cells | Blood cells | T cell receptors | Tumor cell lines | Gene expression | Interleukin 15 | White blood cells | CD16 antigen | Biopsy | Antigen-presenting cells | Human performance | Ligands | Genetic engineering | Index Medicus
Journal Article